Success Story: Chinese PhD Student Earns NIW Approval for Advancing Multi-Agent Artificial Intelligence for Health-Related Decision-Making
Client’s Testimonial:
“Thank you so much! It’s been a great pleasure working with you, too. I’ll return for the EB1A application by the end of next year for sure.”
On December 13th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. Student in the field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: China
State of Residence at the Time of Filing: Indiana
Approval Notice Date: December 13th, 2025
Processing Time: 4 months, 26 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of a Ph.D. student from China whose research advances state-of-the-art artificial intelligence systems for health-related decision-making. At the time of filing, the client was conducting advanced research on multi-agent AI systems that learn to collaborate and self-improve over time, with applications in personalized health interventions, nutrition guidance, mental health support, and substance abuse treatment. Despite being at the doctoral training stage, the client demonstrated a strong and independent research profile with clear national relevance.
Research with National Importance
The client’s work focuses on developing collaborative and explainable AI frameworks that improve reasoning, transparency, and robustness in health-related domains. His research applies multi-agent systems, graph-based learning, and explainable recommendation models to address critical public health challenges, including opioid misuse, mental health risks among youth, food insecurity, and healthcare equity. These AI-driven tools support personalized, scalable interventions that align with U.S. priorities in public health innovation, trustworthy AI, and data-driven healthcare delivery.
Academic Record and Recognition
The client has documented his research in 10 peer-reviewed conference papers, 1 peer-reviewed journal article, 5 preprints, and 1 first-authored technical report in leading artificial intelligence and machine learning venues. His work has received 126 independent citations, reflecting growing recognition within the global AI research community. In addition, he has completed at least 15 peer reviews for well-regarded journals and conferences, demonstrating professional trust in his expertise even at the Ph.D. level.
Expert Endorsements
Independent experts emphasized the originality and national relevance of the client’s work.
One recommender stated:
“Overall, it is clear that [Client] is a rising leader in the field of AI/ML and is dedicated to advancing the interests of the United States.”
This assessment highlights the broader impact of the client’s research and its value beyond academic settings.
NIW Approval and Outlook
The I-140 NIW petition was filed on July 17, 2025, received an RFE on August 6, 2025, and was approved on December 13, 2025, under premium processing. With NAILG’s guidance, the client successfully demonstrated that his proposed endeavor has substantial merit and national importance and that he is well-positioned to advance it. He continues his doctoral research in the United States, developing multi-agent AI systems that strengthen personalized health interventions and support the long-term advancement of trustworthy artificial intelligence.